Hanlin Mok
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
Papers in
-
- Prostate Cancer Treatment and Research 3
- Oncology 3
- Co-authors
- Sarki A. Abdulkadir (6 shared papers)Jonathan F. Anker (4 shared papers)Young A. Yoo (3 shared papers)Rajita Vatapalli (3 shared papers)Barbara Lysy (3 shared papers)Huiying Han (2 shared papers)Yara Rodríguez (2 shared papers)Vinay Sagar (2 shared papers)
- Journals
- Journal of Visualized Experiments (2 papers)iScience (1 paper)Nature Communications (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Hanlin Mok
6 papers receiving 460 citations
Hanlin Mok's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 187
- Cancer Research 70
- Immunology 90
- Molecular Biology 292
- Biotechnology 29
Countries citing papers authored by Hanlin Mok
This map shows the geographic impact of Hanlin Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanlin Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanlin Mok more than expected).
Fields of papers citing papers by Hanlin Mok
This network shows the impact of papers produced by Hanlin Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanlin Mok. The network helps show where Hanlin Mok may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanlin Mok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy Hit paper breakdown → | 2019 | 302 |
| 2 | 2018 | 80 | |
| 3 | 2021 | 41 | |
| 4 | 2018 | 31 | |
| 5 | 2018 | 7 | |
| 6 | 2018 | 1 | |
| 7 | 2025 | 0 |
About Hanlin Mok
Hanlin Mok is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Molecular Biology and Epidemiology, having authored 7 papers that have together received 462 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Research and Treatments (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Protein Degradation and Inhibitors (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), FOXO transcription factor regulation (1 paper) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Oncology (187 citations), Cancer Research (70 citations), Immunology (90 citations), Molecular Biology (292 citations) and Biotechnology (29 citations). Hanlin Mok has collaborated with scholars based in United States and China. Frequent co-authors include Sarki A. Abdulkadir, Jonathan F. Anker, Young A. Yoo, Rajita Vatapalli, Barbara Lysy, Huiying Han, Yara Rodríguez, Vinay Sagar, Kenji Unno and Zachary R. Chalmers. Their work appears in journals such as Journal of Visualized Experiments, iScience, Nature Communications, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.